Skip to main content
Skip to main navigation
Invalid credentials.
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical R&D
Biopharmaceutical Sales & Marketing
Biosimilars
Healthcare Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Cardiovascular
Central Nervous System
Diabetes & Endocrinology
Infectious Diseases
Internal Medicine
Oncology
Early Phase Oncology
Translational Oncology
Pediatrics
Public Health Interest
Vaccines
Other Therapeutic Areas
Our Focus
Our Values
Our Heritage
Our Perspectives
Our Leadership
Ethics & Compliance
Investors
Global Locations
Facebook Twitter LinkedIn YouTube
Local Resources: Central Lab, Clinical, ProductMarketing & Sales, Project Management, Regulatory
Operating since: 1997
Patients enrolled: 10,000 - 25,000 in South America (2004-2008)
Studies <250 in South America (12/31/08) (2004-2008)
Workforce: <2,500 in South America
Go to Brazil
Local Resources: Clinical, Project ManagementRegulatory
Operating since: 2000
Patients enrolled: 10,000 - 25,000 in South America (2004 - 2008)
Studies <250 in South America (12/31/08) (2004 - 2008)
Workforce: <2,500 in South America (12/31/08)
Go to Chile
Local Resources: Clinical, Regulatory
Operating since: 2004
Workforce: <2,500 in South America (2004 - 2008)
Go to Colombia
Local Resources: Access to Patients, ClinicalRegulatory Services
Operating since: 2007
Patients enrolled: 200,000 - 250,000 in North America (2004-2008)
Studies >750 in North America (2004 - 2008)
Workforce: 5,000 - 10,000 in North America (12/31/08)
Go to Costa Rica
Local Resources: Central Lab, Clinical, Commercial Project Management, Regulatory
Studies <250 in South America (2004-2008)
Go to Peru
Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates.
The work we do with the biopharmaceutical industry, payers and providers has a profound effect on extending patients’ lives and quality of life around the world. Learn More About Quintiles